ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,705	1,079	1,052	656	771	348
Market Cap Growth	50.32%	2.58%	60.42%	-14.98%	121.46%	-52.48%
Enterprise Value	2,065	1,583	1,175	913	966	535
Last Close Price	79.51	55.28	55.14	40.23	46.08	29.04
PE Ratio	47.47	-	68.00	-	-	-
Forward PE	10.26	10.72	14.04	14.79	12.86	7.15
PS Ratio	1.90	1.76	2.16	2.07	3.57	1.67
PB Ratio	3.29	2.52	2.30	1.94	2.15	1.78
P/TBV Ratio	-	-	5.38	19.39	64.94	96.52
P/FCF Ratio	10.95	22.59	9.56	-	1008.43	38.15
P/OCF Ratio	9.99	16.86	8.85	-	232.23	22.82
PEG Ratio	-	1.38	1.38	1.11	1.02	-
EV/Sales Ratio	2.50	2.58	2.41	2.89	4.47	2.57
EV/EBITDA Ratio	14.50	19.23	10.75	26.93	50.64	18.40
EV/EBIT Ratio	40.48	108.31	23.73	-	-	-
EV/FCF Ratio	13.26	33.14	10.67	-	1263.31	58.56
Debt / Equity Ratio	1.25	1.47	0.62	0.85	0.80	1.02
Debt / EBITDA Ratio	4.36	7.44	2.61	8.26	15.06	6.87
Debt / FCF Ratio	4.06	13.20	2.60	-	375.65	21.88
Asset Turnover	0.61	0.56	0.59	0.41	0.35	0.45
Inventory Turnover	2.20	2.02	1.68	1.48	1.41	1.60
Quick Ratio	1.94	1.93	2.63	2.15	2.61	1.32
Current Ratio	2.58	2.73	3.57	3.46	3.68	2.17
Return on Equity (ROE)	8.66%	-4.18%	4.72%	-13.74%	-15.37%	-11.04%
Return on Assets (ROA)	2.37%	0.83%	3.72%	-2.10%	-2.86%	-2.12%
Return on Invested Capital (ROIC)	4.73%	2.04%	8.51%	-4.58%	-6.04%	-4.26%
Return on Capital Employed (ROCE)	4.50%	1.30%	6.50%	-3.90%	-4.10%	-4.10%
Earnings Yield	2.00%	-1.72%	1.79%	-7.30%	-5.52%	-6.47%
FCF Yield	9.14%	4.43%	10.46%	-6.11%	0.10%	2.62%
Payout Ratio	-	-	8.65%	-	-	-
Buyback Yield / Dilution	-6.95%	-6.18%	-11.89%	-29.09%	-5.28%	0.63%

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q